March 30 (Reuters) - Visiomed Group SA ALVMG.PA :
* PRO FORMA EBITDA OF €1.1M FOR THE YEAR 2021
* CONSOLIDATED GROSS OPERATING MARGIN OF APPROXIMATELY 20%
TARGETED IN 2022
* IN 2021, VISIOMED GROUP ACHIEVED A CONSOLIDATED TURNOVER
OF €
7.2 MILLION
* OUTLOOK 2022: IS AIMING FOR A VERY CLEAR ACCELERATION IN
ITS
PROFITABLE GROWTH
* AT 31 DECEMBER 2021, VISIOMED GROUP HAD €14.1 MILLION IN
EQUITY
AND €6.6 MILLION IN AVAILABLE CASH
* OUTLOOK: EXPECTS TO SEE AN INCREASE IN SALES OF
TELEMEDICINE
SOLUTIONS DRIVEN BY BEWELLCONNECT AND THE EXPANSION OF SMART
SALEM
* IS EXPECTED TO ACHIEVE A NEW RECORD CONSOLIDATED TURNOVER
IN
2022 OF AROUND €25 MILLION
* OUTLOOK: NEW MEDICAL CENTER IN DUBAI INTERNATIONAL
FINANCIAL
WILL OPEN IN THE SPRING OF 2022
Source text for Eikon: ID:nNDL6FMmw5
Further company coverage: ALVMG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))